 |
|
MS patients not receiving medications to slow disease progression, research shows
April 17, 2007WINSTON-SALEM - Neurologists at Wake Forest University Baptist Medical Center have found that many patients diagnosed with multiple sclerosis (MS) are not taking or being prescribed drugs approved to treat the disease.
"When we looked at patients who are being seen by family practitioners and by neurologists, we were surprised at the number of people who are not benefiting from drugs proven to help reduce the side effects of MS," said Cormac O'Donovan, M.D., a neurologist and co-investigator of the study. "Hopefully by educating physicians about the benefits of these drugs and beginning treatment early, we can slow the progression of this disease."
O'Donovan's research was published this month by Biomed Central Medicine on their website at biomedcentral.com.
O'Donovan and his team studied patient visits to family practitioners, neurologists or internists between 1998 and 2004 across the United States. There were an estimated 6.7 million MS patient visits to physicians during this time. Neurologists recorded the most patient visits (50.7 percent).
About 62 percent of patients visiting neurologists and 92 percent seen by family practitioners/internists were not using immunomodulatory agents (IMAs), according to the research. Treatment with IMAs is known to reduce the frequency of relapses and slow disease progression.
Six IMAs have been approved by the U.S. Federal Drug Administration (FDA) for use in treating MS. They are: interferon-1b (sold under the name Betaseron®), interferon-1a (Avonex®), glatiramer acetate (GA or Copaxone®), interferon-1a (Rebif®), mitoxantrone (Novantrone®) and natalizumab (Tysabri®).
"Our study could not determine exactly why these FDA approved drugs were not being prescribed for the treatment of MS," O'Donovan said. "Some individuals may have mild symptoms at first and decide to defer treatment. Other factors may be that physicians are not as familiar with the newer drugs on the market and the risk-to-benefit ratio. Some patients may not even be aware of the pros and cons of IMAs or were advised by their physician that they did not meet the criteria for taking the drug. The increased use of IMAs by neurologists probably reflects greater awareness of the drugs' availability and their use by specialists who more often treat patients with MS. We need to spend some time looking further into the issue."
MS is an inflammatory disease of the central nervous system. It is the second most common cause of neurological disability in young adults. The cause of MS is unknown but environmental factors and genetics are thought to contribute to the onset of the disease.
Wake Forest University Baptist Medical Center
O'Donovan and his team studied patient visits to family practitioners, neurologists or internists between 1998 and 2004 across the United States. There were an estimated 6.7 million MS patient visits to physicians during this time. Neurologists recorded the most patient visits (50.7 percent).
About 62 percent of patients visiting neurologists and 92 percent seen by family practitioners/internists were not using immunomodulatory agents (IMAs), according to the research. Treatment with IMAs is known to reduce the frequency of relapses and slow disease progression.
Six IMAs have been approved by the U.S. Federal Drug Administration (FDA) for use in treating MS. They are: interferon-1b (sold under the name Betaseron®), interferon-1a (Avonex®), glatiramer acetate (GA or Copaxone®), interferon-1a (Rebif®), mitoxantrone (Novantrone®) and natalizumab (Tysabri®).
"Our study could not determine exactly why these FDA approved drugs were not being prescribed for the treatment of MS," O'Donovan said. "Some individuals may have mild symptoms at first and decide to defer treatment. Other factors may be that physicians are not as familiar with the newer drugs on the market and the risk-to-benefit ratio. Some patients may not even be aware of the pros and cons of IMAs or were advised by their physician that they did not meet the criteria for taking the drug. The increased use of IMAs by neurologists probably reflects greater awareness of the drugs' availability and their use by specialists who more often treat patients with MS. We need to spend some time looking further into the issue."
MS is an inflammatory disease of the central nervous system. It is the second most common cause of neurological disability in young adults. The cause of MS is unknown but environmental factors and genetics are thought to contribute to the onset of the disease.
Wake Forest University Baptist Medical Center
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Herceptin Volcanic Eruption Human Genome Tumor Infectious Disease Childhood Obesity Prion Sarcoma Pulmonary Fibrosis Permafrost Atrial Fibrillation Cognitive Function Saturns Rings Volcanic Eruptions Nevirapine Human Papillomavirus Stroke Damage Metabolic Syndrome Walking Milky Way Substance Abuse Trauma Malaria Vaccine Triglycerides Oxidative Stress
See More: Science News Tags
Neurologist Current Events and Neurologist News RSSSmoking more than 5 cigarettes a day provokes migraine attacks
Tobacco acts as a precipitating factor for headaches, specifically migraines. This is indicated in a study which shows that smokers have more migraine attacks and that smoking more than five cigarettes a day triggers this headache.
Telemedicine Expands Reach of Care for Parkinson's Patients
A unique and innovative telemedicine project is providing distant nursing home patients with Parkinson's disease access to neurologists at the University of Rochester Medical Center (URMC).
Farmed fish may pose risk for mad cow disease
University of Louisville neurologist Robert P. Friedland, M.D., questions the safety of eating farmed fish in the June issue of the Journal of Alzheimer's Disease, adding a new worry to concerns about the nation's food supply.
Protein regulates movement of mitochondria in brain cells
Scientists have identified a protein in the brain that plays a key role in the function of mitochondria - the part of the cell that supplies energy, supports cellular activity, and potentially wards off threats from disease.
An innovative surgical technique gives hope to patients suffering from refractory epilepsy
Clinicians from the Centre hospitalier de l'Université de Montréal (CHUM) have perfected an operation, which was previously considered too dangerous, to control refractory insular epilepsy, using an innovative microsurgery technique.
Muscular dystrophy diagnosis delayed almost 2.5 years in boys
Boys show signs of Duchenne Muscular Dystrophy (DMD) for 2 ½ years before they obtain a diagnosis and disease-specific treatment, about the same length of delay children have endured for the past 20 years despite advances in genetic testing and treatment.
First Neuroimaging Study Examining Motor Execution in Children With Autism Reveals Brain Activation Differences, Decreased Connectivity Between Brain Regions
In the first neuroimaging study to examine motor execution in children with autism, researchers at the Kennedy Krieger Institute have uncovered important new insight into the neurological basis of autism.
Safe exercise for migraine sufferers
Many patients who suffer from migraines avoid taking aerobic exercise because they are afraid that the physical activity may bring on a serious migraine attack.
Tourette syndrome misconceptions only one battle for patients
The most disabling aspect of Tourette syndrome is that in 90% of cases, it exists in conjunction with another disorder.
Test quickly assesses whether Alzheimer's drugs are hitting their target
A test developed by physician-scientists at Washington University School of Medicine in St. Louis may help assess more quickly the ability of Alzheimer's drugs to affect one of the possible underlying causes of Alzheimer's disease in humans, accelerating the development of new treatments.
More Neurologist Current Events and Neurologist News Articles
 |
Neurology for the Non-Neurologist (Weiner, Neurology for the Non-Neurologist) by William J Weiner (Editor), Christopher G Goetz (Editor) The thoroughly updated Fifth Edition of this popular book provides a practical introduction to contemporary neurology for nonspecialists. It offers straightforward guidance on diagnosis and management of all disorders affecting the central and peripheral nervous systems. Each chapter includes case studies with multiple-choice questions, plus a bulleted list indicating when to consult a neurologist. This edition features increased emphasis on treatment, including drugs, devices, and rehabilitation. The authors provide complete information on all new neurologic drugs--including dosage and interactions--and discuss herbal and alternative medicines where appropriate. This edition also includes more tables and illustrations to speed clinicians' access to information. |
 |
Psychiatry for Neurologists by Humana Press A panel of international psychiatrists, neurologists, clinical psychologists, and neuropsychiatrists review for the clinical neurologist those aspects of psychiatry that impact the management of neurological disorders. On the one hand, the authors illuminate the neurological aspects of such psychiatric disorders as depression, anxiety disorders, schizophrenia, hysteria, catatonia, addictions, and personality disorders. On the other hand, they also explain in detail the psychiatric evaluation of the neurological patient and discuss the behavioral aspects of the major neurological disorders, including psychiatric complications of dementia and stroke, neuromuscular disorders, the psychiatric aspects of Parkinson's disease, epilepsy, Huntington's disease, Tourette's syndrome, and multiple... |
 |
The Brain Has a Mind of Its Own: Insights from a Practicing Neurologist by Richard Restak M.D. (Author) Neurologist and best-selling author Richard Restak puts readers in touch with the latest scientific findings about the most complex and inscrutable object in creation--the human brain. "By all means let Richard Restak take you on this lively journey to the very roots of our being. Along the way you will gain new understanding of consciousness, dreams, drugs, emotions, memory loss, and many kindred subjects."--William Warner Line drawings. |
 |
Neurology for the Non-neurologist Deep Pocket series by SELF This is a book with a rapid review of key topics in Neurology. I wrote this for Medical Students and physician who do not feel comfortable with neurology. I have updated it over the last 5 years. Dr. Gould is a neurologist and he has been working on updating the book. Harvey Castro MD, is an Emergency Medicine Physician in Dallas Texas. Dr. Jeffery Gould is a Neurologist in Bethlehem, Pa. The book has many pearls, as well as interesting Zebras. I encourage to look at the preview chapters. We are updating the book wait until we update this book before buying at the 24.95 price |
 |
`Neurological Combo Buck Hammr W/ 256 Cps T.F. A special 5 in 1 tool for the neurologist * This fork by MediSply Nerve/-Sensory-Evaluators A special 5 in 1 tool for the neurologist * This fork combines the basic weighted medical fork with the needle brush pinwheel and two different size hammer tips for quickness and convenience when doing neuropathic work * |
 |
SWEATSHIRT WOMAN NAVY BLUE " SIMPLE WORD NEUROLOGIST " Large |
 |
Worlds Greatest Neurologist Baby Ultrasoft Onesie job, jobs, employment, i love, funny, t-shirt, shirt, gift,work, trust me i'm, a, an,world's, worlds, gift,kiss, number,1, one, best, greatest, biggest, funny, neuro, neurology, nerve, neurologist, neurosurgeon, surgeon Category: Business & Professional |
 |
Jean-Martin Charcot French Neurologist with Some of His Patients Depicted in the Background Collections Giclee Poster Print by Paul Renouard, 9x12 by Art.com Art.com is the world's largest retailer of art prints, posters, photographs, and framed artwork. With our huge selection of over 400,000 prints, you'll easily find the perfect piece for your home, office, or classroom. Our art is printed on quality paper. When you order framed artwork, the piece is built by our team of in-house professionals. Visit our Amazon store today at www.amazon.com/artdotcom to find Special Offers and search for products based on 'Artist Name' and 'Subject Categories' such as Movie, Music, Vintage, TV, Children, Travel, Kitchen, Museum Art, Animals, Floral, Motivational, and Sports. Art.com is dedicated to providing you with high quality products and service by offering you 100% satisfaction guaranteed. We ship internationally to over 80 countries. Decorate your... |
 |
Research-Based Strategies to Ignite Student Learning: Insights from a Neurologist and Classroom Teacher by Judy Willis (Author) Research-Based Strategies to Ignite Student Learning is the first book for educators written by an author who is both a neurologist and a classroom teacher. Dr. Willis used her neurology expertise to examine the past two decades of learning-centered brain research. Using her background and experience as a clinical neurologist and neuroscience researcher, she sifted through the abundance of neuroimaging and brain mapping information. She assessed what information was both valid and relevant to education. She then employed her training and experience as a classroom teacher to provide strategies for implementing the best of this research in the classroom. She brings this knowledge to life in a comprehensive and accessible style. Teachers will be introduced to strategies that will work in... |
 |
ABC News Nightline The Messenger: Dr. Fred Among the most difficult and dangerous operations is the removal of tumors from a child's brain stem or spinal cord. Any parent with a child suffering from that condition has a rather special perspective on what's important. For children with brain and spinal cord tumors, Dr. Epstein can mean the difference between life and death and is one of the few people in the world who can bring hope to these parents and their children. |
| © 2009 BrightSurf.com |